海泰新光股价跌5.25%,信达澳亚基金旗下1只基金重仓,持有26万股浮亏损失69.68万元

Group 1 - The core point of the news is that Haitai New Light has experienced a significant decline in stock price, dropping 5.25% to 48.40 CNY per share, with a total market value of 5.802 billion CNY and a cumulative decline of 6.7% over the past five days [1] - Haitai New Light specializes in the research, production, and sales of medical endoscope instruments and optical products, with revenue composition being 64.86% from medical endoscopes, 21.63% from optical products, 13.09% from maintenance services, and 0.42% from leasing [1] - The fund "Xinda Aoyuan Fund" holds a significant position in Haitai New Light, with a 4.7% allocation in its net value, and has incurred a floating loss of approximately 696,800 CNY due to the recent stock price decline [2] Group 2 - The fund manager of "Xinda Aoyuan Fund" has a long tenure, with the lead manager having 17 years and 91 days of experience, achieving a best return of 109.1% during their tenure [3] - The fund "Xinda Aoyuan Fund" has a total asset size of 216 million CNY and has performed well this year with a return of 25.95%, ranking 3231 out of 8154 in its category [2]

NovelBeam Technology-海泰新光股价跌5.25%,信达澳亚基金旗下1只基金重仓,持有26万股浮亏损失69.68万元 - Reportify